Non-invasive preimplantation genetic testing (NI-PGT) is a technique used in assisted reproductive technology (ART) to assess the genetic makeup of embryos before they are implanted into the uterus during in vitro fertilization (IVF).

The global Non-invasive Preimplantation Genetic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Non-invasive Preimplantation Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Non-invasive Preimplantation Genetic Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Non-invasive Preimplantation Genetic Testing include Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, Abbott, TAKARA, QIAGEN and Vitrolife, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Non-invasive Preimplantation Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Preimplantation Genetic Testing.

Report Scope

The Non-invasive Preimplantation Genetic Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-invasive Preimplantation Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-invasive Preimplantation Genetic Testing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Non-invasive Preimplantation Genetic Testing Market Report

Report Metric	Details
Report Name	Non-invasive Preimplantation Genetic Testing Market
Segment by Type	Preimplantation Genetic Screening Preimplantation Genetic Diagnosis
Segment by Application	Hospitals Diagnostic Laboratories Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, Abbott, TAKARA, QIAGEN, Vitrolife, Oxford Nanopore Technologies, Yikon Genomics, Shiva Scientific, Medicover Genetics, MedGenome, Fulgent, INVICTA GENETICS, Genea Fertility, Bioarray, GeneMind Biosciences, Unimed Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-invasive Preimplantation Genetic Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-invasive Preimplantation Genetic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Non-invasive Preimplantation Genetic Testing Market report?

Ans: The main players in the Non-invasive Preimplantation Genetic Testing Market are Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, Abbott, TAKARA, QIAGEN, Vitrolife, Oxford Nanopore Technologies, Yikon Genomics, Shiva Scientific, Medicover Genetics, MedGenome, Fulgent, INVICTA GENETICS, Genea Fertility, Bioarray, GeneMind Biosciences, Unimed Biotech

What are the Application segmentation covered in the Non-invasive Preimplantation Genetic Testing Market report?

Ans: The Applications covered in the Non-invasive Preimplantation Genetic Testing Market report are Hospitals, Diagnostic Laboratories, Other

What are the Type segmentation covered in the Non-invasive Preimplantation Genetic Testing Market report?

Ans: The Types covered in the Non-invasive Preimplantation Genetic Testing Market report are Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis

1 Non-invasive Preimplantation Genetic Testing Market Overview

1.1 Product Overview and Scope of Non-invasive Preimplantation Genetic Testing

1.2 Non-invasive Preimplantation Genetic Testing Segment by Type

1.2.1 Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Type (2024-2030)

1.2.2 Preimplantation Genetic Screening

1.2.3 Preimplantation Genetic Diagnosis

1.3 Non-invasive Preimplantation Genetic Testing Segment by Application

1.3.1 Global Non-invasive Preimplantation Genetic Testing Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Other

1.4 Global Non-invasive Preimplantation Genetic Testing Market Size Estimates and Forecasts

1.4.1 Global Non-invasive Preimplantation Genetic Testing Revenue 2019-2030

1.4.2 Global Non-invasive Preimplantation Genetic Testing Sales 2019-2030

1.4.3 Global Non-invasive Preimplantation Genetic Testing Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Non-invasive Preimplantation Genetic Testing Market Competition by Manufacturers

2.1 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Manufacturers (2019-2024)

2.2 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Non-invasive Preimplantation Genetic Testing Average Price by Manufacturers (2019-2024)

2.4 Global Non-invasive Preimplantation Genetic Testing Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Product Type & Application

2.7 Non-invasive Preimplantation Genetic Testing Market Competitive Situation and Trends

2.7.1 Non-invasive Preimplantation Genetic Testing Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Non-invasive Preimplantation Genetic Testing Players Market Share by Revenue

2.7.3 Global Non-invasive Preimplantation Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Non-invasive Preimplantation Genetic Testing Retrospective Market Scenario by Region

3.1 Global Non-invasive Preimplantation Genetic Testing Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Non-invasive Preimplantation Genetic Testing Global Non-invasive Preimplantation Genetic Testing Sales by Region: 2019-2030

3.2.1 Global Non-invasive Preimplantation Genetic Testing Sales by Region: 2019-2024

3.2.2 Global Non-invasive Preimplantation Genetic Testing Sales by Region: 2025-2030

3.3 Global Non-invasive Preimplantation Genetic Testing Global Non-invasive Preimplantation Genetic Testing Revenue by Region: 2019-2030

3.3.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Region: 2019-2024

3.3.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Region: 2025-2030

3.4 North America Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country

3.4.1 North America Non-invasive Preimplantation Genetic Testing Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Non-invasive Preimplantation Genetic Testing Sales by Country (2019-2030)

3.4.3 North America Non-invasive Preimplantation Genetic Testing Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country

3.5.1 Europe Non-invasive Preimplantation Genetic Testing Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2019-2030)

3.5.3 Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country

3.6.1 Asia Pacific Non-invasive Preimplantation Genetic Testing Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Non-invasive Preimplantation Genetic Testing Sales by Country (2019-2030)

3.6.3 Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country

3.7.1 Latin America Non-invasive Preimplantation Genetic Testing Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Non-invasive Preimplantation Genetic Testing Sales by Country (2019-2030)

3.7.3 Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Non-invasive Preimplantation Genetic Testing Market Facts & Figures by Country

3.8.1 Middle East and Africa Non-invasive Preimplantation Genetic Testing Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2019-2030)

3.8.3 Middle East and Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Non-invasive Preimplantation Genetic Testing Sales by Type (2019-2030)

4.1.1 Global Non-invasive Preimplantation Genetic Testing Sales by Type (2019-2024)

4.1.2 Global Non-invasive Preimplantation Genetic Testing Sales by Type (2025-2030)

4.1.3 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2019-2030)

4.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2019-2030)

4.2.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2019-2024)

4.2.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Type (2025-2030)

4.2.3 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2019-2030)

4.3 Global Non-invasive Preimplantation Genetic Testing Price by Type (2019-2030)

5 Segment by Application

5.1 Global Non-invasive Preimplantation Genetic Testing Sales by Application (2019-2030)

5.1.1 Global Non-invasive Preimplantation Genetic Testing Sales by Application (2019-2024)

5.1.2 Global Non-invasive Preimplantation Genetic Testing Sales by Application (2025-2030)

5.1.3 Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2019-2030)

5.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2019-2030)

5.2.1 Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2019-2024)

5.2.2 Global Non-invasive Preimplantation Genetic Testing Revenue by Application (2025-2030)

5.2.3 Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2019-2030)

5.3 Global Non-invasive Preimplantation Genetic Testing Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Illumina

6.1.1 Illumina Corporation Information

6.1.2 Illumina Description and Business Overview

6.1.3 Illumina Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Illumina Non-invasive Preimplantation Genetic Testing Product Portfolio

6.1.5 Illumina Recent Developments/Updates

6.2 Thermo Fisher Scientific

6.2.1 Thermo Fisher Scientific Corporation Information

6.2.2 Thermo Fisher Scientific Description and Business Overview

6.2.3 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product Portfolio

6.2.5 Thermo Fisher Scientific Recent Developments/Updates

6.3 Agilent

6.3.1 Agilent Corporation Information

6.3.2 Agilent Description and Business Overview

6.3.3 Agilent Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Agilent Non-invasive Preimplantation Genetic Testing Product Portfolio

6.3.5 Agilent Recent Developments/Updates

6.4 Revvity

6.4.1 Revvity Corporation Information

6.4.2 Revvity Description and Business Overview

6.4.3 Revvity Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Revvity Non-invasive Preimplantation Genetic Testing Product Portfolio

6.4.5 Revvity Recent Developments/Updates

6.5 The Cooper Companies

6.5.1 The Cooper Companies Corporation Information

6.5.2 The Cooper Companies Description and Business Overview

6.5.3 The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.5.4 The Cooper Companies Non-invasive Preimplantation Genetic Testing Product Portfolio

6.5.5 The Cooper Companies Recent Developments/Updates

6.6 Abbott

6.6.1 Abbott Corporation Information

6.6.2 Abbott Description and Business Overview

6.6.3 Abbott Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Abbott Non-invasive Preimplantation Genetic Testing Product Portfolio

6.6.5 Abbott Recent Developments/Updates

6.7 TAKARA

6.6.1 TAKARA Corporation Information

6.6.2 TAKARA Description and Business Overview

6.6.3 TAKARA Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.4.4 TAKARA Non-invasive Preimplantation Genetic Testing Product Portfolio

6.7.5 TAKARA Recent Developments/Updates

6.8 QIAGEN

6.8.1 QIAGEN Corporation Information

6.8.2 QIAGEN Description and Business Overview

6.8.3 QIAGEN Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.8.4 QIAGEN Non-invasive Preimplantation Genetic Testing Product Portfolio

6.8.5 QIAGEN Recent Developments/Updates

6.9 Vitrolife

6.9.1 Vitrolife Corporation Information

6.9.2 Vitrolife Description and Business Overview

6.9.3 Vitrolife Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Vitrolife Non-invasive Preimplantation Genetic Testing Product Portfolio

6.9.5 Vitrolife Recent Developments/Updates

6.10 Oxford Nanopore Technologies

6.10.1 Oxford Nanopore Technologies Corporation Information

6.10.2 Oxford Nanopore Technologies Description and Business Overview

6.10.3 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product Portfolio

6.10.5 Oxford Nanopore Technologies Recent Developments/Updates

6.11 Yikon Genomics

6.11.1 Yikon Genomics Corporation Information

6.11.2 Yikon Genomics Non-invasive Preimplantation Genetic Testing Description and Business Overview

6.11.3 Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Yikon Genomics Non-invasive Preimplantation Genetic Testing Product Portfolio

6.11.5 Yikon Genomics Recent Developments/Updates

6.12 Shiva Scientific

6.12.1 Shiva Scientific Corporation Information

6.12.2 Shiva Scientific Non-invasive Preimplantation Genetic Testing Description and Business Overview

6.12.3 Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Shiva Scientific Non-invasive Preimplantation Genetic Testing Product Portfolio

6.12.5 Shiva Scientific Recent Developments/Updates

6.13 Medicover Genetics

6.13.1 Medicover Genetics Corporation Information

6.13.2 Medicover Genetics Non-invasive Preimplantation Genetic Testing Description and Business Overview

6.13.3 Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Medicover Genetics Non-invasive Preimplantation Genetic Testing Product Portfolio

6.13.5 Medicover Genetics Recent Developments/Updates

6.14 MedGenome

6.14.1 MedGenome Corporation Information

6.14.2 MedGenome Non-invasive Preimplantation Genetic Testing Description and Business Overview

6.14.3 MedGenome Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.14.4 MedGenome Non-invasive Preimplantation Genetic Testing Product Portfolio

6.14.5 MedGenome Recent Developments/Updates

6.15 Fulgent

6.15.1 Fulgent Corporation Information

6.15.2 Fulgent Non-invasive Preimplantation Genetic Testing Description and Business Overview

6.15.3 Fulgent Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Fulgent Non-invasive Preimplantation Genetic Testing Product Portfolio

6.15.5 Fulgent Recent Developments/Updates

6.16 INVICTA GENETICS

6.16.1 INVICTA GENETICS Corporation Information

6.16.2 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Description and Business Overview

6.16.3 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.16.4 INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product Portfolio

6.16.5 INVICTA GENETICS Recent Developments/Updates

6.17 Genea Fertility

6.17.1 Genea Fertility Corporation Information

6.17.2 Genea Fertility Non-invasive Preimplantation Genetic Testing Description and Business Overview

6.17.3 Genea Fertility Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Genea Fertility Non-invasive Preimplantation Genetic Testing Product Portfolio

6.17.5 Genea Fertility Recent Developments/Updates

6.18 Bioarray

6.18.1 Bioarray Corporation Information

6.18.2 Bioarray Non-invasive Preimplantation Genetic Testing Description and Business Overview

6.18.3 Bioarray Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.18.4 Bioarray Non-invasive Preimplantation Genetic Testing Product Portfolio

6.18.5 Bioarray Recent Developments/Updates

6.19 GeneMind Biosciences

6.19.1 GeneMind Biosciences Corporation Information

6.19.2 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Description and Business Overview

6.19.3 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.19.4 GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product Portfolio

6.19.5 GeneMind Biosciences Recent Developments/Updates

6.20 Unimed Biotech

6.20.1 Unimed Biotech Corporation Information

6.20.2 Unimed Biotech Non-invasive Preimplantation Genetic Testing Description and Business Overview

6.20.3 Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales, Revenue and Gross Margin (2019-2024)

6.20.4 Unimed Biotech Non-invasive Preimplantation Genetic Testing Product Portfolio

6.20.5 Unimed Biotech Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Non-invasive Preimplantation Genetic Testing Industry Chain Analysis

7.2 Non-invasive Preimplantation Genetic Testing Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Non-invasive Preimplantation Genetic Testing Production Mode & Process

7.4 Non-invasive Preimplantation Genetic Testing Sales and Marketing

7.4.1 Non-invasive Preimplantation Genetic Testing Sales Channels

7.4.2 Non-invasive Preimplantation Genetic Testing Distributors

7.5 Non-invasive Preimplantation Genetic Testing Customers

8 Non-invasive Preimplantation Genetic Testing Market Dynamics

8.1 Non-invasive Preimplantation Genetic Testing Industry Trends

8.2 Non-invasive Preimplantation Genetic Testing Market Drivers

8.3 Non-invasive Preimplantation Genetic Testing Market Challenges

8.4 Non-invasive Preimplantation Genetic Testing Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Oxford Nanopore Technologies

List of Tables

Table 1. Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Non-invasive Preimplantation Genetic Testing Market Competitive Situation by Manufacturers in 2023

Table 4. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Non-invasive Preimplantation Genetic Testing Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Non-invasive Preimplantation Genetic Testing Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Non-invasive Preimplantation Genetic Testing, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Product Type & Application

Table 12. Global Key Manufacturers of Non-invasive Preimplantation Genetic Testing, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Non-invasive Preimplantation Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Preimplantation Genetic Testing as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Non-invasive Preimplantation Genetic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Non-invasive Preimplantation Genetic Testing Sales by Region (2019-2024) & (K Units)

Table 18. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2019-2024)

Table 19. Global Non-invasive Preimplantation Genetic Testing Sales by Region (2025-2030) & (K Units)

Table 20. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2025-2030)

Table 21. Global Non-invasive Preimplantation Genetic Testing Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2019-2024)

Table 23. Global Non-invasive Preimplantation Genetic Testing Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2025-2030)

Table 25. North America Non-invasive Preimplantation Genetic Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Non-invasive Preimplantation Genetic Testing Sales by Country (2019-2024) & (K Units)

Table 27. North America Non-invasive Preimplantation Genetic Testing Sales by Country (2025-2030) & (K Units)

Table 28. North America Non-invasive Preimplantation Genetic Testing Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Non-invasive Preimplantation Genetic Testing Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2019-2024) & (K Units)

Table 32. Europe Non-invasive Preimplantation Genetic Testing Sales by Country (2025-2030) & (K Units)

Table 33. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Non-invasive Preimplantation Genetic Testing Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Non-invasive Preimplantation Genetic Testing Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Non-invasive Preimplantation Genetic Testing Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Non-invasive Preimplantation Genetic Testing Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Non-invasive Preimplantation Genetic Testing Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Non-invasive Preimplantation Genetic Testing Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Type (2019-2024)

Table 51. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Type (2025-2030)

Table 52. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2019-2024)

Table 53. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Type (2025-2030)

Table 54. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2019-2024)

Table 57. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Type (2025-2030)

Table 58. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Type (2019-2024)

Table 59. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Type (2025-2030)

Table 60. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Application (2019-2024)

Table 61. Global Non-invasive Preimplantation Genetic Testing Sales (K Units) by Application (2025-2030)

Table 62. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2019-2024)

Table 63. Global Non-invasive Preimplantation Genetic Testing Sales Market Share by Application (2025-2030)

Table 64. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Non-invasive Preimplantation Genetic Testing Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2019-2024)

Table 67. Global Non-invasive Preimplantation Genetic Testing Revenue Market Share by Application (2025-2030)

Table 68. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Application (2019-2024)

Table 69. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Application (2025-2030)

Table 70. Illumina Corporation Information

Table 71. Illumina Description and Business Overview

Table 72. Illumina Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Illumina Non-invasive Preimplantation Genetic Testing Product

Table 74. Illumina Recent Developments/Updates

Table 75. Thermo Fisher Scientific Corporation Information

Table 76. Thermo Fisher Scientific Description and Business Overview

Table 77. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Thermo Fisher Scientific Non-invasive Preimplantation Genetic Testing Product

Table 79. Thermo Fisher Scientific Recent Developments/Updates

Table 80. Agilent Corporation Information

Table 81. Agilent Description and Business Overview

Table 82. Agilent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Agilent Non-invasive Preimplantation Genetic Testing Product

Table 84. Agilent Recent Developments/Updates

Table 85. Revvity Corporation Information

Table 86. Revvity Description and Business Overview

Table 87. Revvity Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Revvity Non-invasive Preimplantation Genetic Testing Product

Table 89. Revvity Recent Developments/Updates

Table 90. The Cooper Companies Corporation Information

Table 91. The Cooper Companies Description and Business Overview

Table 92. The Cooper Companies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. The Cooper Companies Non-invasive Preimplantation Genetic Testing Product

Table 94. The Cooper Companies Recent Developments/Updates

Table 95. Abbott Corporation Information

Table 96. Abbott Description and Business Overview

Table 97. Abbott Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Abbott Non-invasive Preimplantation Genetic Testing Product

Table 99. Abbott Recent Developments/Updates

Table 100. TAKARA Corporation Information

Table 101. TAKARA Description and Business Overview

Table 102. TAKARA Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. TAKARA Non-invasive Preimplantation Genetic Testing Product

Table 104. TAKARA Recent Developments/Updates

Table 105. QIAGEN Corporation Information

Table 106. QIAGEN Description and Business Overview

Table 107. QIAGEN Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. QIAGEN Non-invasive Preimplantation Genetic Testing Product

Table 109. QIAGEN Recent Developments/Updates

Table 110. Vitrolife Corporation Information

Table 111. Vitrolife Description and Business Overview

Table 112. Vitrolife Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Vitrolife Non-invasive Preimplantation Genetic Testing Product

Table 114. Vitrolife Recent Developments/Updates

Table 115. Oxford Nanopore Technologies Corporation Information

Table 116. Oxford Nanopore Technologies Description and Business Overview

Table 117. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Oxford Nanopore Technologies Non-invasive Preimplantation Genetic Testing Product

Table 119. Oxford Nanopore Technologies Recent Developments/Updates

Table 120. Yikon Genomics Corporation Information

Table 121. Yikon Genomics Description and Business Overview

Table 122. Yikon Genomics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Yikon Genomics Non-invasive Preimplantation Genetic Testing Product

Table 124. Yikon Genomics Recent Developments/Updates

Table 125. Shiva Scientific Corporation Information

Table 126. Shiva Scientific Description and Business Overview

Table 127. Shiva Scientific Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Shiva Scientific Non-invasive Preimplantation Genetic Testing Product

Table 129. Shiva Scientific Recent Developments/Updates

Table 130. Medicover Genetics Corporation Information

Table 131. Medicover Genetics Description and Business Overview

Table 132. Medicover Genetics Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Medicover Genetics Non-invasive Preimplantation Genetic Testing Product

Table 134. Medicover Genetics Recent Developments/Updates

Table 135. MedGenome Corporation Information

Table 136. MedGenome Description and Business Overview

Table 137. MedGenome Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. MedGenome Non-invasive Preimplantation Genetic Testing Product

Table 139. MedGenome Recent Developments/Updates

Table 140. Fulgent Corporation Information

Table 141. Fulgent Description and Business Overview

Table 142. Fulgent Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Fulgent Non-invasive Preimplantation Genetic Testing Product

Table 144. Fulgent Recent Developments/Updates

Table 145. INVICTA GENETICS Corporation Information

Table 146. INVICTA GENETICS Description and Business Overview

Table 147. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. INVICTA GENETICS Non-invasive Preimplantation Genetic Testing Product

Table 149. INVICTA GENETICS Recent Developments/Updates

Table 150. Genea Fertility Corporation Information

Table 151. Genea Fertility Description and Business Overview

Table 152. Genea Fertility Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 153. Genea Fertility Non-invasive Preimplantation Genetic Testing Product

Table 154. Genea Fertility Recent Developments/Updates

Table 155. Bioarray Corporation Information

Table 156. Bioarray Description and Business Overview

Table 157. Bioarray Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 158. Bioarray Non-invasive Preimplantation Genetic Testing Product

Table 159. Bioarray Recent Developments/Updates

Table 160. GeneMind Biosciences Corporation Information

Table 161. GeneMind Biosciences Description and Business Overview

Table 162. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 163. GeneMind Biosciences Non-invasive Preimplantation Genetic Testing Product

Table 164. GeneMind Biosciences Recent Developments/Updates

Table 165. Unimed Biotech Corporation Information

Table 166. Unimed Biotech Description and Business Overview

Table 167. Unimed Biotech Non-invasive Preimplantation Genetic Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 168. Unimed Biotech Non-invasive Preimplantation Genetic Testing Product

Table 169. Unimed Biotech Recent Developments/Updates

Table 170. Key Raw Materials Lists

Table 171. Raw Materials Key Suppliers Lists

Table 172. Non-invasive Preimplantation Genetic Testing Distributors List

Table 173. Non-invasive Preimplantation Genetic Testing Customers List

Table 174. Non-invasive Preimplantation Genetic Testing Market Trends

Table 175. Non-invasive Preimplantation Genetic Testing Market Drivers

Table 176. Non-invasive Preimplantation Genetic Testing Market Challenges

Table 177. Non-invasive Preimplantation Genetic Testing Market Restraints

Table 178. Research Programs/Design for This Report

Table 179. Key Data Information from Secondary Sources

Table 180. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Non-invasive Preimplantation Genetic Testing

Figure 2. Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Non-invasive Preimplantation Genetic Testing Market Share by Type in 2023 & 2030

Figure 4. Preimplantation Genetic Screening Product Picture

Figure 5. Preimplantation Genetic Diagnosis Product Picture

Figure 6. Global Non-invasive Preimplantation Genetic Testing Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Non-invasive Preimplantation Genetic Testing Market Share by Application in 2023 & 2030

Figure 8. Hospitals

Figure 9. Diagnostic Laboratories

Figure 10. Other

Figure 11. Global Non-invasive Preimplantation Genetic Testing Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Non-invasive Preimplantation Genetic Testing Market Size (2019-2030) & (US$ Million)

Figure 13. Global Non-invasive Preimplantation Genetic Testing Sales (2019-2030) & (K Units)

Figure 14. Global Non-invasive Preimplantation Genetic Testing Average Price (US$/Unit) & (2019-2030)

Figure 15. Non-invasive Preimplantation Genetic Testing Report Years Considered

Figure 16. Non-invasive Preimplantation Genetic Testing Sales Share by Manufacturers in 2023

Figure 17. Global Non-invasive Preimplantation Genetic Testing Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Non-invasive Preimplantation Genetic Testing Players: Market Share by Revenue in 2023

Figure 19. Non-invasive Preimplantation Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Non-invasive Preimplantation Genetic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2019-2030)

Figure 22. North America Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2019-2030)

Figure 23. United States Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2019-2030)

Figure 26. Europe Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2019-2030)

Figure 27. Germany Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Non-invasive Preimplantation Genetic Testing Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Non-invasive Preimplantation Genetic Testing Revenue Market Share by Region (2019-2030)

Figure 34. China Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2019-2030)

Figure 42. Latin America Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Non-invasive Preimplantation Genetic Testing Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Non-invasive Preimplantation Genetic Testing Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Non-invasive Preimplantation Genetic Testing Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Non-invasive Preimplantation Genetic Testing by Type (2019-2030)

Figure 52. Global Revenue Market Share of Non-invasive Preimplantation Genetic Testing by Type (2019-2030)

Figure 53. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Non-invasive Preimplantation Genetic Testing by Application (2019-2030)

Figure 55. Global Revenue Market Share of Non-invasive Preimplantation Genetic Testing by Application (2019-2030)

Figure 56. Global Non-invasive Preimplantation Genetic Testing Price (US$/Unit) by Application (2019-2030)

Figure 57. Non-invasive Preimplantation Genetic Testing Value Chain

Figure 58. Non-invasive Preimplantation Genetic Testing Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions